Wortmannin and LY294002, for instance, are potent inhibitors of phosphoinositide 3-kinases (PI3K), an upstream regulator in the PI3K/Akt signaling cascade. By hindering this pathway, they indirectly impact the phosphorylation and activation states of proteins that are downstream, including potentially LOC730094. This modulation can lead to a variety of cellular responses, including alterations in cell growth and survival. Similarly, Triciribine acts upon Akt, a central protein in the PI3K pathway, to alter the function of downstream proteins. Rapamycin, by inhibiting the mechanistic target of rapamycin (mTOR), affects a central node in cellular growth and metabolism. This inhibition can induce a cascading effect that potentially alters the activity of LOC730094 by changing the cellular environment and protein synthesis patterns. PD98059 and U0126, which target the MAPK/ERK pathway by inhibiting MEK, can affect gene expression and protein function in a way that may intersect with the activity of LOC730094.
SP600125 and SB203580 selectively inhibit JNK and p38 MAPK, respectively. These kinases are involved in cellular responses to stress and inflammation, and their inhibition can lead to changes in the cellular milieu that may indirectly modulate LOC730094's function. The compound PP2, a Src family kinase inhibitor, impacts cell adhesion and survival, potentially altering signaling pathways that LOC730094 could be part of. Moreover, the inhibitor Y-27632, which targets the Rho-associated protein kinase (ROCK), can influence the organization of the actin cytoskeleton, affecting processes such as migration and cell shape, which could, in turn, influence the function or localization of LOC730094. Bortezomib, a proteasome inhibitor, alters the degradation of a multitude of proteins, potentially stabilizing proteins that regulate or interact with LOC730094. Lastly, Thapsigargin, by inhibiting the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), disrupts calcium homeostasis, leading to a wide array of downstream effects that could influence various proteins, including LOC730094.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Inhibits phosphoinositide 3-kinases (PI3K), potentially affecting proteins downstream of PI3K signaling. | ||||||
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $104.00 $141.00 | 14 | |
Inhibits Akt, which is part of the PI3K pathway and may affect proteins that are regulated by Akt. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR, a key regulator of cell growth and proliferation, affecting proteins associated with the mTOR signaling pathway. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK, which is involved in the MAPK/ERK pathway, potentially influencing proteins downstream of this pathway. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, similar to Wortmannin, affecting proteins involved in the PI3K/Akt signaling pathway. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, which can alter the activity of proteins that are regulated by the JNK signaling pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAPK, potentially affecting proteins that are modulated by the p38 MAPK signaling pathway. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Inhibits MEK1/2 in the MAPK/ERK pathway, potentially affecting proteins downstream in the pathway. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
Inhibits Src family kinases, which may affect proteins downstream of Src signaling pathways. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Inhibits ROCK, which is involved in regulating the actin cytoskeleton, potentially affecting associated proteins. | ||||||